SILC Silicom Ltd
Silicom Ltd (SILC) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $1.0M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Orbach Yeshayhu | Director | Sell | 2,969 | $45.00 | $133.6K | None left | |
| Eizenman Avinoam | Director | Sell | 20,000 | $50.50 | $1.0M | 168,736 −10.6% of holding | |
| Eizenman Liron | President and CEO | Sell | 18,072 | $48.53 | $877.0K | 9,928 −64.5% of holding | |
| Gilad Eran 2 fills | CFO | Sell | 7,000 | $44.45 | $311.1K | 6,975 −50.1% of holding | |
| Karp Yuval | EVP Project Management | Sell | 2,000 | $50.00 | $100.0K | None left | |
| Castiel David | VP Engineering | Sell | 2,000 | $48.00 | $96.0K | None left | |
| Hendel David | VP R&D | Sell | 1,000 | $49.00 | $49.0K | None left | |
| COHEN DANIEL (DC) | EVP Operation | Sell | 15 | $52.00 | $780 | 1,985 −0.8% of holding | |
| Hendel David 2 fills | VP R&D | Sell | 1,000 | $44.37 | $44.4K | 1,500 −40% of holding | |
| Eizenman Avinoam | Director | Sell | 9,023 | $44.66 | $403.0K | 188,736 −4.6% of holding | |
| Eizenman Liron | President and CEO | Sell | 8,900 | $45.23 | $402.5K | 15,500 −36.5% of holding | |
| Gilad Eran | CFO | Sell | 6,000 | $44.18 | $265.1K | None left | |
| Hendel David | VP R&D | Sell | 500 | $45.00 | $22.5K | 2,000 −20% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.